WinstonWınston
Back
Venture Life Group logo

Venture Life Group

VLG.L
42
Drug Manufacturers - Specialty & Generic · Healthcare
Price
66.00 GBp
+0.50 (+0.76%)
Market Cap
£79.8M
Exchange
London Stock Exchange
Winston Score
42
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Dec 31, 2025
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Weak
Stability
Good
Valuation
Strong
Dividends
Good

Share count rising — dilution

+4.7% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 133.8M (2021) → 140.0M (2025)

Winston Score History

The full picture

Venture Life Group is a UK-based healthcare company that develops and sells consumer healthcare products — things like oral care, skincare, and personal hygiene items that people buy without a prescription. Its products are sold under its own brands as well as manufactured for other companies under private-label arrangements, meaning retailers or other brands put their own name on Venture Life's products. The company serves pharmacies, retailers, and healthcare professionals mainly across Europe.

Venture Life makes money by selling finished products directly and by manufacturing products for third-party clients, giving it two revenue streams. It operates primarily in the UK and continental Europe and is a small company with a market cap around $100 million. Its competitive position relies on owning niche product formulations and having established distribution relationships, but with an operating margin of just 3% and a very low return on invested capital, the main risk is that thin profitability leaves little room for error if costs rise or sales growth slows.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+530.1% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+445.4% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

£0/ year

Declining (-100% vs prior year)

0.0% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

12.9%ownership

Declining

Insider ownership declining — could be dilution or selling

Cash Runway

~9 years

£34M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

£34M cash & investments at current burn rate

Revenue accelerating

Venture Life Group grew revenue 530% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
36.3%
Modest — 36.3% gross margin
Profit after running costs
Operating Margin
7.4%
Modest — 7.4% operating margin
Return on the money invested
ROCE
1.3%
Weak — 1.3% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+32.2%
Fast-growing sales (+32.2% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
8%
Weak — only 8% of profit becomes cash
Spare cash per sale
FCF Margin
1.2%
Thin free cash flow (1.2%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.01
Conservative — low debt load (0.01)
Covers its interest
Interest Cover
0.70x
Dangerous — barely covers interest (0.7x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
15.1x
Fair value — P/E 15.1

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
+4.7
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (15.1 → 10.4)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
6.05%
Healthy income — 6.05% yield

Yield above 6% — often a flag the market is pricing in a cut.

Dividend record
Dividend Growth
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial